vimarsana.com

Latest Breaking News On - Sangamo therapeutics daily - Page 1 : vimarsana.com

Sangamo Therapeutics (NASDAQ:SGMO) Receives Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report issued on Wednesday morning, Benzinga reports. They currently have a $5.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at ($0.05) […]

HC Wainwright Reaffirms Buy Rating for Sangamo Therapeutics (NASDAQ:SGMO)

HC Wainwright reissued their buy rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $5.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at […]

Sangamo Therapeutics (SGMO) Scheduled to Post Quarterly Earnings on Thursday

Sangamo Therapeutics (SGMO) Scheduled to Post Quarterly Earnings on Thursday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.